Cargando…

Accelerated hyper-versus normofractionated radiochemotherapy with temozolomide in patients with glioblastoma: a multicenter retrospective analysis

BACKGROUND AND PURPOSE: The standard treatment of glioblastoma patients consists of surgery followed by normofractionated radiotherapy (NFRT) with concomitant and adjuvant temozolomide chemotherapy. Whether accelerated hyperfractionated radiotherapy (HFRT) yields comparable results to NFRT in combin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klement, Rainer J., Popp, Ilinca, Kaul, David, Ehret, Felix, Grosu, Anca L., Polat, Bülent, Sweeney, Reinhart A., Lewitzki, Victor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817053/ https://www.ncbi.nlm.nih.gov/pubmed/34940951 http://dx.doi.org/10.1007/s11060-021-03926-0

Ejemplares similares

Accelerated hyperfractionated radiochemotherapy with temozolomide is equivalent to normofractionated radiochemotherapy in a retrospective analysis of patients with glioblastoma
por: Lewitzki, Victor, et al.
Publicado: (2019)

Normofractionated irradiation and not temozolomide modulates the immunogenic and oncogenic phenotype of human glioblastoma cell lines
por: Schatz, Julia, et al.
Publicado: (2022)

Toxicity after radiochemotherapy for glioblastoma using temozolomide - a retrospective evaluation
por: Niewald, Marcus, et al.
Publicado: (2011)

Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: The CLEOPATRA Trial
por: Combs, Stephanie E, et al.
Publicado: (2010)

Bilateral posterior RION after concomitant radiochemotherapy with temozolomide in a patient with glioblastoma multiforme: a case report
por: Schreiber, Stefanie, et al.
Publicado: (2010)

Accelerated hyperfractionation plus temozolomide in glioblastoma
por: Kaul, David, et al.
Publicado: (2016)

External Validation of the Graded Prognostic Assessment in Patients with Brain Metastases from Small Cell Lung Cancer
por: Nieder, Carsten, et al.
Publicado: (2022)

PRO: Do We Still Need Whole-Brain Irradiation for Brain Metastases?
por: Popp, Ilinca, et al.
Publicado: (2023)

Effectiveness of hypofractionated and normofractionated radiotherapy in a triple‐negative breast cancer model
por: Grosche, Sinja, et al.
Publicado: (2022)

Impact of a ketogenic diet intervention during radiotherapy on body composition: I. Initial clinical experience with six prospectively studied patients
por: Klement, Rainer J., et al.
Publicado: (2016)

Face masks in radiation oncology clinics: based on evidence or source of mistakes?
por: Klement, Rainer J., et al.
Publicado: (2020)

Impact of a ketogenic diet intervention during radiotherapy on body composition: V. Final results of the KETOCOMP study for head and neck cancer patients
por: Klement, Rainer J., et al.
Publicado: (2022)

FET-PET radiomics in recurrent glioblastoma: prognostic value for outcome after re-irradiation?
por: Carles, Montserrat, et al.
Publicado: (2021)

Validation of the graded prognostic assessment for gastrointestinal cancers with brain metastases (GI-GPA)
por: Nieder, Carsten, et al.
Publicado: (2020)

Problems associated with a highly artificial ketogenic diet: Letter to the Editor Re: van der Louw EJTM, Olieman JF, van den Bemt PMLA, et al. ‘Ketogenic diet treatment as adjuvant to standard treatment of glioblastoma multiforme: a feasibility and safety study’
por: Klement, Rainer Johannes, et al.
Publicado: (2019)

The role of neoadjuvant radiochemotherapy in the management of localized high-grade soft tissue sarcoma
por: Kobus, Marta, et al.
Publicado: (2022)

Differences in stem cell marker and osteopontin expression in primary and recurrent glioblastoma
por: Polat, Bülent, et al.
Publicado: (2022)

Phase I/II study testing the combination of AGuIX nanoparticles with radiochemotherapy and concomitant temozolomide in patients with newly diagnosed glioblastoma (NANO-GBM trial protocol)
por: Thivat, Emilie, et al.
Publicado: (2023)

A ketogenic diet exerts beneficial effects on body composition of cancer patients during radiotherapy: An interim analysis of the KETOCOMP study
por: Klement, Rainer J., et al.
Publicado: (2019)

Normofractionated and moderately hypofractionated proton therapy: comparison of acute toxicity and early quality of life outcomes
por: Pelak, Maciej J., et al.
Publicado: (2022)

Radiochemotherapy
Publicado: (1998)

Normofractionated stereotactic radiotherapy versus CyberKnife-based hypofractionation in skull base meningioma: a German and Italian pooled cohort analysis
por: Alfredo, Conti, et al.
Publicado: (2019)

RADIANCE – Radiochemotherapy with or without Durvalumab in the treatment of anal squamous cell carcinoma: A randomized multicenter phase II trial
por: Martin, Daniel, et al.
Publicado: (2020)

Concurrent Chemoradiotherapy with Temozolomide Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients: A Retrospective Multicenter Observation Study in Korea
por: Kim, Byung Sup, et al.
Publicado: (2017)

Temozolomide resistance in glioblastoma multiforme
por: Lee, Sang Y.
Publicado: (2016)

Optimization of hippocampus sparing during whole brain radiation therapy with simultaneous integrated boost—tutorial and efficacy of complete directional hippocampal blocking
por: Popp, Ilinca, et al.
Publicado: (2022)

Correction to: Normofractionated stereotactic radiotherapy versus CyberKnife-based hypofractionation in skull base meningioma: a German and Italian pooled cohort analysis
por: Conti, Alfredo, et al.
Publicado: (2020)

Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial comparing arm A standard radiochemotherapy to arm B radiochemotherapy with simultaneous integrated boost guided by MR spectroscopic imaging
por: Laprie, Anne, et al.
Publicado: (2019)

Evolution of the hypoxic compartment on sequential oxygen partial pressure maps during radiochemotherapy in advanced head and neck cancer
por: Lazzeroni, Marta, et al.
Publicado: (2021)

A Comprehensive Prospective Comparison of Acute Skin Toxicity after Hypofractionated and Normofractionated Radiation Therapy in Breast Cancer
por: Borm, Kai J., et al.
Publicado: (2021)

Patient-Reported Quality of Life Outcomes after Moderately Hypofractionated and Normofractionated Proton Therapy for Localized Prostate Cancer
por: Nakajima, Koichiro, et al.
Publicado: (2022)

Strategies of temozolomide in future glioblastoma treatment
por: Lee, Chooi Yeng
Publicado: (2017)

Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma
por: Saha, Dipongkor, et al.
Publicado: (2020)

Postoperative adjuvant radiochemotherapy with cisplatin versus adjuvant radiochemotherapy with cisplatin and pembrolizumab in locally advanced head and neck squamous cell carcinoma- the study protocol of the Adrisk trial
por: Wiegand, Susanne, et al.
Publicado: (2023)

External validation of a prognostic score predicting overall survival for patients with brain metastases based on extracranial factors
por: Lewitzki, Victor, et al.
Publicado: (2019)

Leptomeningeal and intramedullary metastases of glioblastoma multiforme in a patient reoperated during adjuvant radiochemotherapy
por: Grah, Josip Joachim, et al.
Publicado: (2013)

Alterations in Molecular Profiles Affecting Glioblastoma Resistance to Radiochemotherapy: Where Does the Good Go?
por: Vilar, Juliana B., et al.
Publicado: (2022)

Temozolomide during and after Radiotherapy for Newly Diagnosed Glioblastomas : A Prospective Multicenter Study of Korean Patients
por: Joo, Jin-Deok, et al.
Publicado: (2012)

Polymer–Temozolomide Conjugates as Therapeutics for Treating Glioblastoma
por: Ward, Sarah M., et al.
Publicado: (2018)

Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma
por: JIAPAER, Shabierjiang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ng9bb41352j7an3sq5j0p1rrfm